This study is in progress, not accepting new patients
A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- SecuraBio
- ID
- NCT03372057
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 120 study participants
- Last Updated